Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Get Free Report)’s stock price passed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $0.00 and traded as high as $0.62. Xtant Medical shares last traded at $0.59, with a volume of 14,499 shares.
Xtant Medical Stock Down 5.2 %
The company has a debt-to-equity ratio of 0.42, a quick ratio of 0.88 and a current ratio of 2.12. The company has a market capitalization of $77.85 million, a price-to-earnings ratio of -4.31 and a beta of 0.35.
Institutional Investors Weigh In On Xtant Medical
A hedge fund recently raised its stake in Xtant Medical stock. Geode Capital Management LLC boosted its position in shares of Xtant Medical Holdings, Inc. (NYSEAMERICAN:XTNT – Free Report) by 70.2% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 515,006 shares of the medical device company’s stock after acquiring an additional 212,394 shares during the period. Geode Capital Management LLC owned 0.37% of Xtant Medical worth $348,000 at the end of the most recent quarter. 69.33% of the stock is owned by institutional investors.
About Xtant Medical
Xtant Medical Holdings, Inc provides regenerative medicine products and medical devices for orthopedic and neurological surgeons. It offers OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSelect DBM Putty to mold into any shape and compressed into bony voids; OsteoSelect PLUS DBM Putty to deliver handling properties and ensure patient safety through validated terminal sterilization; 3Demin, a family of allografts that maximizes osteoconductivity and the osteoinductive potential of human bone; OsteoFactor, a processed allograft that contains retained growth factors found within the endosteum layer of allograft bone; OsteoVive Plus, a growth factor enriched cellular bone matrix; and nanOss family of products that provide osteoconductive nano-structured hydroxyapatite and an engineered extracellular matrix bioscaffold collagen carrier.
See Also
- Five stocks we like better than Xtant Medical
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- The Significance of Brokerage Rankings in Stock Selection
- DuPont’s Electronics Spinoff: The Start of Something Big
- What is the Australian Securities Exchange (ASX)
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Xtant Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xtant Medical and related companies with MarketBeat.com's FREE daily email newsletter.
